110124 ⎘
dsRNA viruses; Details; Reoviridae; Orbivirus, e.g. bluetongue virus Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
PLANT-PRODUCED CHIMAERIC ORBIVIRUS VLPS
#2Plant-produced chimaeric orbivirus VLPs
#3Recombinant modified vaccinia virus ankara (MVA) equine encephalitis virus vaccine
#4Epizootic hemorrhagic disease vaccine
#5Plant-produced chimaeric Orbivirus VLPs
#6Reoviridae vaccine
#7Recombinant modified vaccinia virus Ankara (MVA) equine encephalitis virus vaccine
#8A BLUETONGUE VACCINE AND METHODS OF MANUFACTURE THEREOF
#9BLUETONGUE VIRUS RECOMBINANT VACCINES AND USES THEREOF
#10Vaccines for diseases caused by viruses of the family of reoviridae
#11Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same
#12Method for producing vaccinal viral strain of a virus of the family
#13Reassortant BTV and AHSV vaccines
#14VACCINE AGAINST AFRICAN HORSE SICKNESS VIRUS
#15Bluetongue virus recombinant vaccines and uses thereof
#16FOOT AND MOUTH DISEASE VIRUS RECOMBINANT VACCINES AND USES THEREOF
#17HETERLOGOUS PRIME-BOOST IMMUNIZATION REGIMEN
#18Inactivated Live-Attenuated Bluetongue Virus Vaccine
#19Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same
#20Method for producing vaccinal viral strain of a virus of the reoviridae family
#21Vaccine against african horse sickness virus
#22Recombinant vaccine against bluetongue virus
#23Methods and Compositions Comprising Protein L Immunoglobulin Binding Domains for Cell-Specific Targeting